Sim AS - Search Results

1

Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity.

Wang XL, Sim AS, Wang MX, Murrell GA, Trudinger B, Wang J. Wang XL, et al. Among authors: sim as. FEBS Lett. 2000 Apr 7;471(1):45-50. doi: 10.1016/s0014-5793(00)01356-9. FEBS Lett. 2000. PMID: 10760510 Free article.

2

Glutathione S-transferase mu1 deficiency, cigarette smoking and coronary artery disease.

Wang XL, Greco M, Sim AS, Duarte N, Wang J, Wilcken DE. Wang XL, et al. Among authors: sim as. J Cardiovasc Risk. 2002 Feb;9(1):25-31. doi: 10.1177/174182670200900104. J Cardiovasc Risk. 2002. PMID: 11984214

3

Effect of CYP1A1 MspI polymorphism on cigarette smoking related coronary artery disease and diabetes.

Wang XL, Greco M, Sim AS, Duarte N, Wang J, Wilcken DE. Wang XL, et al. Among authors: sim as. Atherosclerosis. 2002 Jun;162(2):391-7. doi: 10.1016/s0021-9150(01)00723-7. Atherosclerosis. 2002. PMID: 11996959

4

A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene.

Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE. Wang XL, et al. Among authors: sim as. Nat Med. 1996 Jan;2(1):41-5. doi: 10.1038/nm0196-41. Nat Med. 1996. PMID: 8564837

5

Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels.

Wang XL, Mahaney MC, Sim AS, Wang J, Wang J, Blangero J, Almasy L, Badenhop RB, Wilcken DE. Wang XL, et al. Among authors: sim as. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3147-53. doi: 10.1161/01.atv.17.11.3147. Arterioscler Thromb Vasc Biol. 1997. PMID: 9409304

6

MspI polymorphism in the promoter of the human endothelial constitutive NO synthase gene in Australian Caucasian population.

Sim AS, Wang J, Wilcken D, Wang XL. Sim AS, et al. Mol Genet Metab. 1998 Sep;65(1):62. doi: 10.1006/mgme.1998.2741. Mol Genet Metab. 1998. PMID: 9787097 No abstract available.

7

L-arginine regulates asymmetric dimethylarginine metabolism by inhibiting dimethylarginine dimethylaminohydrolase activity in hepatic (HepG2) cells.

Wang J, Sim AS, Wang XL, Wilcken DE. Wang J, et al. Among authors: sim as. Cell Mol Life Sci. 2006 Dec;63(23):2838-46. doi: 10.1007/s00018-006-6271-8. Cell Mol Life Sci. 2006. PMID: 17075694 Free PMC article.

8

Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism.

Wilcken DE, Sim AS, Wang J, Wang XL. Wilcken DE, et al. Among authors: sim as. Mol Genet Metab. 2007 Aug;91(4):309-17; discussion 308. doi: 10.1016/j.ymgme.2007.04.017. Epub 2007 Jun 7. Mol Genet Metab. 2007. PMID: 17560156 Review.

9

Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease.

Wang J, Sim AS, Wang XL, Salonikas C, Naidoo D, Wilcken DE. Wang J, et al. Among authors: sim as. Atherosclerosis. 2006 Feb;184(2):383-8. doi: 10.1016/j.atherosclerosis.2005.05.002. Epub 2005 Jun 6. Atherosclerosis. 2006. PMID: 15939423

10

The effect on transcription efficiency of the apolipoprotein AI gene of DNA variants at the 5' untranslated region.

Wang XL, Badenhop RB, Sim AS, Wilcken DE. Wang XL, et al. Among authors: sim as. Int J Clin Lab Res. 1998;28(4):235-41. doi: 10.1007/s005990050051. Int J Clin Lab Res. 1998. PMID: 9879497

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters